OVERVIEW

This seminar aims to enhance clinicians’ expertise in psychopharmacology by thoroughly exploring key concepts and contemporary practices. Participants will engage with a variety of conceptual models, comparing symptom-oriented and disease-oriented treatment approaches. We will critically evaluate the diagnostic validity of major psychiatric conditions and investigate evidence-based medication strategies tailored to these disorders. 

The presentation places a strong emphasis on diagnostic accuracy and the application of research-driven clinical practices, prioritizing efficacy and safety as demonstrated in clinical trials over speculative biological mechanisms. In-depth analysis and treatment strategies will be provided for schizophrenia, bipolar disorder, depression, and anxiety disorders, with additional focus on mixed states, bipolar depression, and the nuanced role of psychopharmacology in optimizing treatment outcomes.  

The seminar will incorporate the latest research findings, including recent advancements in clinical psychopharmacology, to ensure participants are equipped with up-to-date knowledge and skills. Special attention will be given to the application of these strategies in diverse patient populations, including children, the elderly, and those with comorbid medical conditions, to promote holistic and effective patient care.

TARGET AUDIENCE

Health professionals in psychiatry, psychology, neurology, medicine, surgery, geriatrics, pediatrics, nursing, social work, and counseling

LEARNING OBJECTIVES

• Describe a historical background on the major themes to be covered during the course;
  
• Discuss the biological mechanisms of major psychotropic drug classes; 
• Grasp the basic neuroanatomy relevant to clinical psychopharmacology; 
• Recognize and apply key clinical trials of drug classes for various diagnoses; 
• Examine the validity of DSM diagnoses and learn how to use non-DSM approaches to diagnosis and drug treatment; 
• Discuss practices with antipsychotics, mood stabilizers, and antidepressants; 
• Explain the risks and side effects of major drug classes; 
• Employ medications with an understanding of pharmacokinetic interactions;
• Identify factors in medication use for those with comorbid medical conditions.

ACCREDITATION

PHYSICIAN CREDIT: 

University of Miami Leonard M. Miller School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University of Miami Leonard M. Miller School of Medicine designates these live activities for a maximum of 15 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The Royal College of Physicians and Surgeons of Canada recognizes conferences and workshops held outside of Canada that are developed by a university, academy, hospital, specialty society or college as accredited group learning activities.

Through an agreement between the American Medical Association and the European Union of Medical Specialists, physicians may convert AMA PRA Category 1 Credit™ to an equivalent number of European CME Credits® (ECMECs®).

PSYCHOLOGIST CREDIT:

The University of Miami Leonard M. Miller School of Medicine is approved by the American Psychological Association (APA) to sponsor continuing education for psychologists. The University of Miami Leonard M. Miller School of Medicine maintains responsibility for this program and its content. 15.00 CE credits will be awarded to psychologists for attendance at these seminars.

NURSE PRACTITIONERS & REGISTERED NURSES CREDIT:

These activities have been submitted to ANA Massachusetts for approval to award contact hours. ANA Massachusetts is accredited as an approver of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

For more information please visit the official event page.